BioMarin Clinical Trials logo
  • Guide to Clinical Trials
    • Understanding Clinical Trials
    • Our Commitment
    • FAQs
  • Areas of Clinical Research
    • Achondroplasia
    • Alpha-1 Antitrypsin Deficiency
    • Duchenne Muscular Dystrophy
    • Hypochondroplasia
    • Idiopathic Short Stature
    • Noonan Syndrome
    • Phenylketonuria
    • SHOX Deficiency
    • Turner Syndrome
  • HCP
  • BioMarin.com
Contact
  • Contact

Hypochondroplasia

Hypochondroplasia, a form of skeletal dysplasia, is a rare genetic condition caused by gain-of-function variation to a gene that plays a key role in developing and maintaining bones. This results in reduced endochondral bone growth and short stature.

Learn more about our active hypochondroplasia clinical trials below.

Hypochondroplasia Clinical Trials

NCT06212947

Trial Status Recruiting

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Learn More

NCT06455059

Trial Status Enrolling By Invitation

Interventional Study of Vosoritide for the Treatment of Children with Hypochondroplasia

Learn More

Print

Understanding Clinical Trials

Mother and child sit opposite a doctor at a desk

Our Commitment

Miranda Newquist in San Rafael Lab

Frequently Asked Questions

HCP filling out paperwork

You're leaving the BioMarin Clinical Trials website.

This will take you to BioMarin.com, our global corporate website. Some of the information on BioMarin.com is intended for U.S. audiences only.

Leave this website Close

You’re leaving the BioMarin Clinical Trials website.

Links to sites outside of this website are provided as a resource to the viewer. BioMarin accepts no responsibility for the content of linked sites.

Leave this website Close

BioMarin Clinical Trials logo
  • Privacy Policy
  • Terms of Use
  • Supply Chain Statement
  • Report an Adverse Event
  • Cookie Settings
  • LinkedIn
  • X
  • Instagram
  • Facebook

© 2025 BioMarin. All rights reserved. MMRC-MPRL-00150 03/25